Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1

Lin, Xi, Antalffy, Barbara, Kang, Dongcheul, Orr, Harry T., Zoghbi, Huda Y.·2000·Nature Neuroscience

Cited by (374)

Items 201–300 of 374

  1. Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in Drosophila
    Leeanne McGurk, Nancy M. Bonini · 2011 · Human Molecular Genetics
  2. Nuclear localization of N‐terminal mutant huntingtin is cell cycle dependent
    Ester Martı́n-Aparicio, Jesús Ávila, José J. Lucas · 2002 · European Journal of Neuroscience
  3. Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies.
    Judit M. Perez Ortiz, H. Orr · 2018 · Advances in Experimental Medicine and Biology
  4. Brainstem and striatal volume changes are detectable in under 1 year and predict motor decline in spinocerebellar ataxia type 1
    T. Koscik, Lauren M. Sloat, E. van der Plas, J. Joers, D. Deelchand, C. Lenglet, G. Öz, P. Nopoulos · 2020 · Brain Communications
  5. Positioning the genome within the nucleus
    Pernette J. Verschure · 2004 · Biology of the Cell
  6. Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxia
    Sherry-Ann N. Brown, Leslie M. Loew · 2012 · BMC Systems Biology
  7. Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1
    Ravi Chopra, David D. Bushart, John-Paul R. Cooper, Dhananjay Yellajoshyula, Logan M. Morrison, Hao-Ran Huang, Hillary P. Handler, Lu-Ke J. Man, Warunee Dansithong, D. Scoles et al. · 2020 · bioRxiv
  8. Suppression of Calbindin-D28k Expression Exacerbates SCA1 Phenotype in a Disease Mouse Model
    Parminder J. S. Vig, Jinrong Wei, Qingmei Shao, Maripar E. Lopez, Rebecca F. Halperin, Jill D. Gerber · 2011 · The Cerebellum
  9. Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity
    Morwena Latouche, Pascal Fragner, Elodie Martin, Khalid Hamid El Hachimi, Cecilia Soussi Zander, Annie Sittler, Merle Ruberg, Alexis Brice, Giovanni Stévanin · 2005 · Molecular and Cellular Neuroscience
  10. Therapeutic gene silencing strategies for polyglutamine disorders
    Janine Scholefield, Matthew J. A. Wood · 2009 · Trends in Genetics
  11. Amino Acids in a Region of Ataxin-1 Outside of the Polyglutamine Tract Influence the Course of Disease in SCA1 Transgenic Mice
    Pamela J. Skinner, Cynthia Vierra‐Green, Effat S. Emamian, Huda Yahya Zoghbi, Harry T. Orr · 2002 · NeuroMolecular Medicine
  12. Protein Aggregation and Polyasparagine-Mediated Cellular Toxicity inSaccharomyces cerevisiae
    Theodore W. Peters, Mingxia Huang · 2007 · Prion
  13. Region‐specific preservation of Purkinje cell morphology and motor behavior in the ATXN1[82Q] mouse model of spinocerebellar ataxia 1
    Joshua J. White, Laurens W. J. Bosman, François G. C. Blot, Catarina Osório, Bram W. Kuppens, Wilhelmina H. J. J. Krijnen, Charlotte A. Andriessen, Chris I. De Zeeuw, Dick Jaarsma, Martijn Schonewille · 2021 · Brain Pathology
  14. Kaleidoscopic protein–protein interactions in the life and death of ataxin-1: new strategies against protein aggregation
    Cesira de Chiara, Annalisa Pastore · 2014 · Trends in Neurosciences
  15. LANP mediates neuritic pathology in Spinocerebellar ataxia type 1
    M. Cvetanovic, Rupinder Kular, Puneet Opal · 2012 · Neurobiology of Disease
  16. Posterior cerebellar Purkinje cells in an SCA5/SPARCA1 mouse model are especially vulnerable to the synergistic effect of loss of β-III spectrin and GLAST
    Emma Perkins, Daumante Šuminaite, Yvonne L. Clarkson, Sin Kwan Lee, Alastair Robert Lyndon, Jeffrey D. Rothstein, David J. A. Wyllie, Kohichi Tanaka, M. T. Jackson · 2016 · Human Molecular Genetics
  17. Pharmacological enhancement of retinoid-related orphan receptor α function mitigates spinocerebellar ataxia type 3 pathology.
    Masashi Watanave, Chiaki Hoshino, A. Konno, Y. Fukuzaki, Y. Matsuzaki, T. Ishitani, H. Hirai · 2019 · Neurobiology of Disease
  18. The Ins and Outs of a Polyglutamine Neurodegenerative Disease: Spinocerebellar Ataxia Type 1 (SCA1)
    Harry T. Orr · 2000 · Neurobiology of Disease
  19. Prenylcysteine carboxylmethyltransferase is essential for the earliest stages of liver development in mice
    Xi Lin, Joonil Jung, Dongcheul Kang, Bisong Xu, Kenneth S. Zaret, Huda Yahya Zoghbi · 2002 · Gastroenterology
  20. Polyglutamine-mediated aggregation and cell death.
    T. de Cristofaro, A. Affaitati, A. Feliciello, E. Avvedimento, S. Varrone · 2000 · Biochemical and Biophysical Research Communications - BBRC
  21. Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing
    Marie Coutelier, Giovanni Stévanin, Alexis Brice · 2015 · Journal of Neurology
  22. Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1
    Marija Cvetanović, Yuan-Shih Hu, Puneet Opal · 2016 · The Cerebellum
  23. Purkinje Neurons with Loss of STIM1 Exhibit Age-Dependent Changes in Gene Expression and Synaptic Components
    Sreeja Kumari Dhanya, Gaiti Hasan · 2021 · Journal of Neuroscience
  24. Isolation of gene sets affected specifically by polyglutamine expression: implication of the TOR signaling pathway in neurodegeneration
    Bryce Nelson, S Nishimura, Hirotaka Kanuka, Erina Kuranaga, Masato Inoue, Gen Hori, Hiroyuki Nakahara, Masayuki Miura · 2005 · Cell Death and Differentiation
  25. Mouse Models of Triplet Repeat Diseases
    Gillian P. Bates, Roman Gonitel · 2006 · Molecular Biotechnology
  26. Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseases
    Bernd Friedrich, Philipp Euler, Ruhtraut Ziegler, Alexandre Kuhn, G. Bernhard Landwehrmeyer, Ruth Luthi‐Carter, Cornelius Weiller, Sabine Hellwig, Birgit Zucker · 2012 · Brain Research
  27. Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 mice
    Ellie M. Carrell, Megan S. Keiser, Ashley B. Robbins, Beverly L. Davidson · 2022 · Molecular Therapy — Methods & Clinical Development
  28. Roles of Double-strand Breaks, Nicks, and Gaps in Stimulating Deletions of CTG·CAG Repeats by Intramolecular DNA Repair
    Micheal L. Hebert, Robert D. Wells · 2005 · Journal of Molecular Biology
  29. Direct Activation of TRPC3 Channels by the Antimalarial Agent Artemisinin
    Nicole D. Urban, Michael Schaefer · 2020 · Cells
  30. Polyglutamine Disorders Including Huntington's Disease
    Sokol V. Todi, Aislinn Joanmarie Williams, Henry Lauris Paulson · 2007 · Elsevier eBooks
  31. Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention?
    J. Paul Taylor, Kenneth H. Fischbeck · 2002 · Trends in Molecular Medicine
  32. Spinocerebellar ataxias caused by polyglutamine expansions.
    G. Stevanin, A. Dürr, A. Brice · 2002 · Advances in Experimental Medicine and Biology
  33. New light on polyglutamine neurodegenerative disorders: interference with transcription
    Christian Néri · 2001 · Trends in Molecular Medicine
  34. Identification of a novel phosphorylation site in ataxin-1
    Cynthia Vierra‐Green, Harry T. Orr, Huda Yahya Zoghbi, Deborah A. Ferrington · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  35. A Novel Central Nervous System–Enriched Spinocerebellar Ataxia Type 7 Gene Product
    David D. Einum, Anna M. Clark, Jeannette J. Townsend, Louis J. Ptáček, Ying‐Hui Fu · 2003 · Archives of Neurology
  36. Excitatory Amino Acid Transporters as Therapeutic Targets in the Treatment of Neurological Disorders: Their Roles and Therapeutic Prospects
    Guirui Zhang, Shupeng Huang, Mingzhen Wei, Yongmo Wu, Jinhui Wang · 2025 · Neurochemical Research
  37. Protein-Protein Interactions as a Strategy towards Protein-Specific Drug Design: The Example of Ataxin-1
    C. de Chiara, R. Menon, G. Kelly, A. Pastore · 2013 · PLoS ONE
  38. Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1
    Yusuke Hatanaka, K. Watase, K. Wada, Y. Nagai · 2015 · Scientific Reports
  39. Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1
    Kyota Fujita, Ying Mao, Shigenori Uchida, Xi-Gu Chen, Hiroki Shiwaku, T. Tamura, Hikaru Ito, K. Watase, Hidenori Homma, K. Tagawa et al. · 2017 · Nature Communications
  40. Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy
    Karine Mérienne, James S. Friedman, Masayuki Akimoto, Gretta Abou Sleymane, Chantal Weber, Anand Swaroop, Yvon Trottier · 2007 · Neurobiology of Disease
  41. Embryonic stem cells expressing expanded CAG repeats undergo aberrant neuronal differentiation and have persistent Oct-4 and REST/NRSF expression
    Matthew T. Lorincz, Peter J. Detloff, Roger L. Albin, K. Sue O’Shea · 2004 · Molecular and Cellular Neuroscience
  42. Molecular pathogenesis of spinal and bulbar muscular atrophy
    Diane E. Merry · 2001 · Brain Research Bulletin
  43. Therapeutic Strategies for Spinocerebellar Ataxia Type 1
    Laurie M.C. Kerkhof, Bart P.C. van de Warrenburg, Willeke van Roon‐Mom, Ronald A.M. Buijsen · 2023 · Biomolecules
  44. Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia
    Sherry-Ann N. Brown, Leslie M. Loew · 2015 · Frontiers in Neuroscience
  45. Motor and Cerebellar Architectural Abnormalities during the Early Progression of Ataxia in a Mouse Model of SCA1 and How Early Prevention Leads to a Better Outcome Later in Life
    Mohamed F. Ibrahim, Emmet M. Power, Kay Potapov, Ruth M. Empson · 2017 · Frontiers in Cellular Neuroscience
  46. Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1
    Kimberly Luttik, Leon Tejwani, Hyoungseok Ju, T. Driessen, C. Smeets, Chandrakanth Reddy Edamakanti, Aryaan Khan, Joy Yun, Puneet Opal, Janghoo Lim · 2022 · Proceedings of the National Academy of Sciences of the United States of America
  47. Huntington's disease
    Raphael M. Bonelli, M. Flint Beal · 2012 · Handbook of clinical neurology
  48. Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice
    Akira Iizuka, Kazuhiro Nakamura, Hirokazu Hirai · 2015 · Neuroscience Letters
  49. The ubiquitin-conjugating enzyme UbcH6 regulates the transcriptional repression activity of the SCA1 gene product ataxin-1.
    Soyeon Lee, Sung-Hoi Hong, Seongman Kang · 2008 · Biochemical and Biophysical Research Communications - BBRC
  50. Gain-of-function screen identifies a role of the Sec61α translocon in Drosophila postmitotic neurotoxicity
    Hirotaka Kanuka, Tetsuo Hiratou, Tatsushi Igaki, Hiroshi Kanda, Erina Kuranaga, Kazunobu Sawamoto, Toshiro Aigaki, Hideyuki Okano, Masayuki Miura · 2005 · Biochimica et Biophysica Acta (BBA) - General Subjects
  51. Gene, Stem Cell, and Alternative Therapies for SCA 1
    Jacob L. Wagner, Deirdre M. A. O’Connor, Anthony Donsante, Nicholas M. Boulis · 2016 · Frontiers in Molecular Neuroscience
  52. Diseases of movement and system degenerations
    Paul G. Ince, Brent Clark, Janice L. Holton, Tamás Révész, Stephen B. Wharton · 2008 · CRC Press eBooks
  53. Localization of ataxin-2 within the cerebellar cortex of the rat
    Francesca Romana Fusco, Maria Teresa Viscomi, Giorgio Bernardi, Marco Molinari · 2001 · Brain Research Bulletin
  54. Functional contributions of glutamate transporters at the parallel fibre to Purkinje neuron synapse–relevance for the progression of cerebellar ataxia
    Emmet M. Power, Ruth M. Empson · 2014 · Cerebellum & Ataxias
  55. Delayed spinocerebellar ataxia in transgenic mice expressing mutant ubiquitin
    Maria Tsirigotis, Mingxiang Tang, M. Beyers, M. Zhang, John Woulfe, Douglas A. Gray · 2005 · Neuropathology and Applied Neurobiology
  56. Hprt (CAG)146 mice: Age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
    Sara J. Tallaksen‐Greene, Jared M. Ordway, Andrew B. Crouse, Walker S. Jackson, Peter J. Detloff, Roger L. Albin · 2003 · The Journal of Comparative Neurology
  57. Radiological hints for differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia
    Hung-Chieh Chen, Li‐Hua Lee, Jiing‐Feng Lirng, Bing‐Wen Soong · 2022 · Scientific Reports
  58. The Emerging Key Role of the mGluR1-PKCγ Signaling Pathway in the Pathogenesis of Spinocerebellar Ataxias: A Neurodevelopmental Viewpoint
    Qin‐Wei Wu, Josef P. Kapfhammer · 2022 · International Journal of Molecular Sciences
  59. Overview of autosomal dominant ataxias
    S. H. Subramony · 2011 · Handbook of clinical neurology
  60. Role of tissue transglutaminase type 2 in calbindin–D28k interaction with ataxin-1
    Parminder J. S. Vig, J. Wei, Qingmei Shao, Michael D. Hebert, Sub H. Subramony, Lamari Sutton · 2007 · Neuroscience Letters
  61. Impact of Reduced Cerebellar EAAT Expression on Purkinje Cell Firing Pattern of NPC1-deficient Mice
    Michael Rabenstein, Franziska Peter, Arndt Rolfs, Moritz J. Frech · 2018 · Scientific Reports
  62. Polyglutamine spinocerebellar ataxias: emerging therapeutic targets
    Andreia Neves‐Carvalho, Sara Duarte‐Silva, Andreia Teixeira‐Castro, Patrı́cia Maciel · 2020 · Expert Opinion on Therapeutic Targets
  63. Dentatorubral-pallidoluysian atrophy (DRPLA)
    Shoji Tsuji · 2000 · Springer eBooks
  64. Pre-ataxic loss of intrinsic plasticity and motor learning in a mouse model of SCA1
    Catarina Osório, Joshua J. White, Heiling Lu, Gerrit Cornelis Beekhof, Francesca Romana Fiocchi, Charlotte A. Andriessen, Stéphanie Dijkhuizen, Laura C. Post, Martijn Schonewille · 2022 · Brain
  65. Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse Cortex
    Kimberly P. Luttik, Víctor Olmos, Ashley Owens, A. Khan, Joy Yun, Terri M. Driessen, Janghoo Lim · 2022 · Cells
  66. Spinobulbar muscular atrophy (Kennedy's disease)
    Jean‐Marc Gallo · 2004 · Handbook of clinical neurophysiology
  67. Spinocerebellar Ataxia Type 10: A Disease Caused by a Large ATTCT Repeat Expansion
    Tohru Matsuura, Tetsuo Ashizawa · 2002 · Advances in experimental medicine and biology
  68. Early apoptotic and late necrotic components associated with altered Ca2+ homeostasis in a peptide‐delivery model of polyglutamine‐induced neuronal death
    Mari Suzuki, Tatsuro Koike · 2005 · Journal of Neuroscience Research
  69. Jan Evangelista Purkyně and the Cerebellum Then and Now
    F Vožeh · 2015 · Physiological Research
  70. Homeostasis of glutamate neurotransmission is altered in Drosophila Inositol 1,4,5-trisphosphate receptor mutants
    S. Nair, Neha Agrawal, G. Hasan · 2007 · Invertebrate Neuroscience
  71. Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxias
    Clévio Nóbrega, Adriana Marcelo, Ana Teresa Rajado, André Conceição, Bernardo Estevam, Carlos A. Matos, David V.C. Brito, Inês T. Afonso, José Miguel Codêsso, Rebekah Koppenol et al. · 2025 · Cell Death and Disease
  72. Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell
    Takafumi Inoue · 2003 · The Keio Journal of Medicine
  73. Autosomal Dominant Spinocerebellar Ataxias and Episodic Ataxias
    Franco Taroni, Luisa Chiapparini, Caterina Mariotti · 2012 · Springer eBooks
  74. Functional Complementation of Drosophila itpr Mutants by Rat Itpr1
    Sumita Chakraborty, Gaiti Hasan · 2012 · Journal of Neurogenetics
  75. Olivocerebellar projections are necessary for exogenous trophic factors to delay heredo-Purkinje cell degeneration
    Brian H. Hess, James A. Krewet, Daniel L. Tolbert · 2003 · Brain Research
  76. Spinocerebellar Ataxia Type 7: Clinical Features to Cellular Pathogenesis
    Gwenn A. Garden, Ray Truant, Lisa Ellerby, Albert R. La Spada · 2006 · Elsevier eBooks
  77. TRPC3 Antagonizes Pruritus in a Mouse Contact Dermatitis Model
    Katherine Beattie, Haowu Jiang, Mayank Gautam, Mary K MacVittie, Barbara A. Miller, Minghong Ma, Qin Liu, Wenqin Luo · 2021 · Journal of Investigative Dermatology
  78. Polyglutamine Diseases and Neurodegeneration: The Example of Ataxin-1
    Cesira de Chiara, Annalisa Pastore · 2011 · Springer eBooks
  79. Qs in the Nucleus
    Harry T. Orr · 2001 · Neuron
  80. Changes in mRNA content of developing opossum spinal cord at stages when regeneration can and cannot occur after injury
    Miranda Mladinić, Marie E. Wintzer · 2002 · Brain Research Reviews
  81. Maladies par expansion de polyglutamine : données moléculaires et physiopathologiques
    Anne-Sophie Lèbre, Alexis Brice · 2001 · médecine/sciences
  82. Triplet Repeat Diseases
    Stephan J. Guyenet, Albert R. La Spada · 2006 · Encyclopedia of Molecular Cell Biology and Molecular Medicine
  83. TRPC3 Channel Activity and Viability of Purkinje Neurons can be Regulated by a Local Signalosome
    Naveed Aslam, Farah Alvi · 2022 · Frontiers in Molecular Biosciences
  84. The neglected role of endocannabinoid actions at TRPC channels in ataxia
    Hoda Ranjbar, Monavareh Soti, Moazamehosadat Razavinasab, Kristi A. Kohlmeier, Mohammad Shabani · 2022 · Neuroscience & Biobehavioral Reviews
  85. The molecular mechanisms of spinocerebellar ataxias for DNA repeat expansion in disease
    Manish Kumar, Nishu Tyagi, Mohammed Faruq · 2023 · Emerging Topics in Life Sciences
  86. Pathological Bergmann glia alterations and disrupted calcium dynamics in ataxic Canavan disease mice
    Vanessa L. Hull, Yan Wang, Travis Burns, Sarah Sternbach, Shuaishuai Gong, Jennifer Ann McDonough, Fuzheng Guo, Laura N. Borodinsky, David Pleasure · 2023 · Glia
  87. Ataxin active site determination using spectral distribution of electron ion interaction potentials of amino acids
    Elena Pirogova, Vuk Vojisavljević, José Luís Hernández Cáceres, Irena Ćosić · 2010 · Medical & Biological Engineering & Computing
  88. Transactivation Domain of Human c-Myc Is Essential to Alleviate Poly(Q)-Mediated Neurotoxicity in Drosophila Disease Models
    Kritika Raj, Surajit Sarkar · 2017 · Journal of Molecular Neuroscience
  89. Degradation properties of polyglutamine-expanded human androgen receptor in transfected cells
    Daniel A. Cullen, P. Nigel Leigh, Jean‐Marc Gallo · 2004 · Neuroscience Letters
  90. Alterations in molecular chaperones and eIF2α during lung endothelial cell apoptosis
    Qing Lü, Matthew D. Jankowich, Julie Newton, Elizabeth O. Harrington, Sharon Rounds · 2010 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  91. Phenotypical, genotypical and pathological characterization of the moonwalker mouse, a model of ataxia
    Gabriella Sekerková, Sumeyra Kilic, Yen-Hsin Cheng, Natalie Fredrick, Anne Osmani, Haram R. Kim, Puneet Opal, Marco Martina · 2024 · Neurobiology of Disease
  92. The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?
    Hiroshi Mitoma, Kazuhiko Yamaguchi, Jérôme Honnorat, Mario Ubaldo Manto · 2022 · Brain Sciences
  93. Recent Advancements in Targeted Delivery of Therapeutic Molecules in Neurodegenerative Disease–-Spinocerebellar Ataxia–-Opportunities and Challenges
    Satya Prakash, Meenakshi Malhotra · 2008 · Drug Target Insights
  94. A survey of trinucleotide/tandem repeat-containing transcripts (TNRTs) isolated from human spinal cord to identify genes containing unstable DNA regions as candidates for disorders of motor function
    Andrea Malaspina, Narendra Kumar Kaushik, Jacqueline de Belleroche · 2001 · Brain Research Bulletin
  95. Pathological Mechanisms in Polyglutamine Expansion Diseases
    Didier Devys, Gaël Yvert, Astrid Lunkes, Yvon Trottier, Jean‐Louis Mandel · 2001 · Advances in experimental medicine and biology
  96. Dominantly Inherited Spinocerebellar Syndromes
    Stephen M. Maricich, Huda Yahya Zoghbi · 2014 · Elsevier eBooks
  97. Chapter 4 Clinical and Genetic Aspects of Spinocerebellar Ataxias with Emphasis on Polyglutamine Expansions
    Giovanni Stévanin, Alexandra Dürr, Alexis Brice · 2007 · Blue books of neurology
  98. Spectrins in Human Diseases
    Marie‐Christine Lecomte · 2012 · Humana Press eBooks
  99. Neurodegeneration in the polyglutamine diseases: Act 1, Scene 1
    Robert Luke Nussbaum, Georg W. J. Auburger · 2000 · Nature Neuroscience
  100. IP3 Receptors in Neurodegenerative Disorders: Spinocerebellar Ataxias and Huntington’s and Alzheimer’s Diseases
    Masayoshi Tada, Masatoyo Nishizawa, Osamu Onodera · 2013 · Springer eBooks